KemPharm Inc. (KMPH): We will continue to disagree as you'...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Re: gi197845 post# 755

Wednesday, 08/04/2021 4:13:45 PM

Wednesday, August 04, 2021 4:13:45 PM

We will continue to disagree as you're assuming max dilution, I'm assuming it isn't needed

I remain positive... no time will be given to negativity... don't waste time on negative forces, move on or remain positive! -doebop

Keep Last Read

Replies (2) Next 10 Prev Next

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/29/2024 11:49:38 AM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/10/2024 08:23:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2024 11:46:20 AM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/09/2024 04:15:27 AM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/03/2024 08:17:44 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/03/2024 08:15:21 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/01/2024 09:27:49 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/30/2023 08:14:13 PM

InvestorsHub NewsWire

Only $200 per official company press release!